Phase 2 Dialysis Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2
Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.
Hemodialysis
London Health Sciences Centre Research Institute60 enrolled1 locationNCT07234890
Recruiting
Phase 2
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
Hemodialysis
Brigham and Women's Hospital100 enrolled1 locationNCT05498181
Recruiting
Phase 1Phase 2
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.12 enrolled1 locationNCT07201467
Recruiting
Phase 2
Activated Charcoal Use in Chronic Kidney Disease Patients
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University40 enrolled1 locationNCT06906874
Recruiting
Phase 2
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
End Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationResidual Kidney Function+1 more
Chinese University of Hong Kong48 enrolled1 locationNCT06483074
Recruiting
Phase 2
Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd.310 enrolled1 locationNCT06976177
Recruiting
Phase 2
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
Chronic Kidney Disease Requiring Hemodialysis
Maximo Agustin Schiavone80 enrolled1 locationNCT06929169
Recruiting
Phase 2
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
Cardiovascular DiseaseCardiovascular Risk FactorChronic Kidney Disease Requiring Chronic Dialysis+2 more
Charite University, Berlin, Germany50 enrolled1 locationNCT06225544
Completed
Phase 2
A feasibility study comparing topical use of acetic acid at the exit site versus mupirocin to prevent exit site infections in peritoneal dialysis patients.
Peritoneal dialysis exit site infection
Mrs Lesley Williams70 enrolled1 locationACTRN12617001286336
Recruiting
Phase 2
Inflammation and Colchicine use in patients with ESRF undergoing Dialysis
Chronic Kidney DiseaseInflammationHaemodialysis
A/Prof Sanjay Patel100 enrolled1 locationACTRN12617000922370
Not Yet Recruiting
Phase 2
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on peritoneal dialysis
Chronic kidney Disease- on peritoneal dialysisType 2 Diabetes
Tilenka Thynne6 enrolled1 locationACTRN12612000864820
Recruiting
Phase 2
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysis
Chronic Renal failure on haemodialysisType 2 Diabetes
Dr Tilenka Thynne6 enrolled1 locationACTRN12612000352808
Completed
Phase 2
The use of 5% tea tree oil for the prevention of infections in renal dialysis patients
Infection in renal dialysis patients
The University of Western Australia100 enrolled1 locationACTRN12610000874011